PRCT
9/6/2024 10:16am
PROCEPT BioRobotics Corporation (PRCT) has reported a significant year-over-year total revenue growth of 61.17% as of June 30, 2024. However, the company has experienced a substantial decline in net profit margin, recording a negative value of -52.69%. This indicates that while the company is growing in terms of revenue, it is not translating into increased profitability. The basic EPS (Earnings Per Share) for PRCT is -$0.5, reflecting the company's current losses.